{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:35Z","timestamp":1792796795245,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01873-1","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:52:01Z","timestamp":1780725121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Omics-driven strategies for identifying biomarkers in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Yumna","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcot","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudasir","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Uniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prawez","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq Mohammed","family":"Aljarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sadique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"publisher","first-page":"e92648","DOI":"10.1371\/journal.pone.0092648","volume":"9","author":"Z Abduljaleel","year":"2014","unstructured":"Abduljaleel Z, Al-Allaf FA, Khan W, Athar M, Shahzad N, Taher MM, Elrobh M, Alanazi MS, El-Huneidi W (2014) Evidence of trem2 variant associated with triple risk of Alzheimer\u2019s disease. PLoS ONE 9:e92648","journal-title":"PLoS ONE"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13195-024-01542-4","volume":"16","author":"S Ahmad","year":"2024","unstructured":"Ahmad S, Yang W, Orellana A, Fr\u00f6lich L, de Rojas I, Cano A, Boada M, Hern\u00e1ndez I, Hausner L, Harms AC, Bakker MHM, Cabrera-Socorro A, Amin N, Ram\u00edrez A, Ruiz A, Van Duijn CM, Hankemeier T (2024) Association of oxidative stress and inflammatory metabolites with Alzheimer\u2019s disease cerebrospinal fluid biomarkers in mild cognitive impairment. Alzheimers Res Ther 16:171","journal-title":"Alzheimers Res Ther"},{"key":"1873_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s11064-022-03771-1","volume":"48","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A (2023) Glial Glutamine Homeostasis in Health and Disease. Neurochem Res 48:1100\u20131128","journal-title":"Neurochem Res"},{"issue":"4","key":"1873_CR4","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"A Andrade-GuerreroJ, Santiago-Balmase","year":"2023","unstructured":"Andrade-GuerreroJ, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C, Pozo-Molina G, M\u00e9ndez-Catal\u00e1 CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Mu\u00f1oz J, Soto-Rojas LO (2023) Alzheimer\u2019s Disease: An updated overview of its genetics. Int J Mol Sci 24(4):3754. https:\/\/doi.org\/10.3390\/ijms24043754","journal-title":"Int J Mol Sci"},{"key":"1873_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2017.01.007","volume":"101","author":"W Andr\u00e9","year":"2017","unstructured":"Andr\u00e9 W, Nondier I, Valensi M, Guillonneau F, Federici C, Hoffner G, Djian P (2017) Identification of brain substrates of transglutaminase by functional proteomics supports its role in neurodegenerative diseases. Neurobiol Dis 101:40\u201358","journal-title":"Neurobiol Dis"},{"key":"1873_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neurobiolaging.2003.10.009","volume":"25","author":"B Arosio","year":"2004","unstructured":"Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer\u2019s disease. Neurobiol Aging 25:1009\u20131015","journal-title":"Neurobiol Aging"},{"key":"1873_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J (2021) Proteomic landscape of Alzheimer\u2019s Disease: novel insights into pathogenesis and biomarker discovery. Mol neurodegeneration 16:55","journal-title":"Mol neurodegeneration"},{"key":"1873_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2018.07.010","volume":"684","author":"J Bratosiewicz-Wasik","year":"2018","unstructured":"Bratosiewicz-Wasik J, Liberski PP, Peplonska B, Styczynska M, Smolen-Dzirba J, Cycon M, Wasik TJ (2018) Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer\u2019s disease. Neurosci Lett 684:86\u201390","journal-title":"Neurosci Lett"},{"key":"1873_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2013.03.019","volume":"1513","author":"G Brinkmalm","year":"2013","unstructured":"Brinkmalm G, Brinkmalm A, Bourgeois P, Persson R, Hansson O, Portelius E, Mercken M, Andreasson U, Parent S, Lipari F, Ohrfelt A, Bjerke M, Minthon L, Zetterberg H, Blennow K, Nutu M (2013) Soluble amyloid precursor protein \u03b1 and \u03b2 in CSF in Alzheimer\u2019s disease. Brain Res 1513:117\u2013126","journal-title":"Brain Res"},{"key":"1873_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160","journal-title":"Nat Rev Neurosci"},{"key":"1873_CR11","doi-asserted-by":"publisher","first-page":"13s","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD (2022) The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. J nuclear medicine: official publication Soc Nuclear Med 63:13s\u201319s","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"key":"1873_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-022-01494-6","volume":"10","author":"S Chen","year":"2022","unstructured":"Chen S, Chang Y, Li L, Acosta D, Li Y, Guo Q, Wang C, Turkes E, Morrison C, Julian D (2022) Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer\u2019s disease. Acta Neuropathol Commun 10:188","journal-title":"Acta Neuropathol Commun"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","volume":"106","author":"D Chiasserini","year":"2014","unstructured":"Chiasserini D, van Weering JR, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE, de Wit H, Jim\u00e9nez CR (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteom 106:191\u2013204","journal-title":"J Proteom"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-021-00814-7","volume":"13","author":"C Clark","year":"2021","unstructured":"Clark C, Dayon L, Masoodi M, Bowman GL, Popp J (2021) An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease. Alzheimers Res Ther 13:71","journal-title":"Alzheimers Res Ther"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature12825","volume":"505","author":"C Cruchaga","year":"2014","unstructured":"Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, Hsu S, Choi J, Ryten M, Sassi C, Bras J, Gibbs RJ, Hernandez DG, Lupton MK, Powell J, Forabosco P, Ridge PG, Corcoran CD, Tschanz JT, Norton MC, Munger RG, Schmutz C, Leary M, Demirci FY, Bamne MN, Wang X, Lopez OL, Ganguli M, Medway C, Turton J, Lord J, Braae A, Barber I, Brown K, Pastor P, Lorenzo-Betancor O, Brkanac Z, Scott E, Topol E, Morgan K, Rogaeva E, Singleton A, Hardy J, Kamboh MI, George-Hyslop PS, Cairns N, Morris JC, Kauwe JSK, Goate AM (2014) Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease. Nature 505:550\u2013554","journal-title":"Nature"},{"key":"1873_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, la Cour CM, Martin WF, Mithieux G, Moreira PI, Murphy MP, Nave KA, Nuriel T, Oliet SHR, Saudou F, Mattson MP, Swerdlow RH, Millan MJ (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discovery 19:609\u2013633","journal-title":"Nat Rev Drug Discovery"},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1021\/acschemneuro.0c00426","volume":"11","author":"RM Dalton","year":"2020","unstructured":"Dalton RM, Krishnan HS, Parker VS, Catanese MC, Hooker JM (2020) Coevolution of Atomic Resolution and Whole-Brain Imaging for Tau Neurofibrillary Tangles. ACS Chem Neurosci 11:2513\u20132522","journal-title":"ACS Chem Neurosci"},{"key":"1873_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-170426","volume":"60","author":"L Dayon","year":"2017","unstructured":"Dayon L, Wojcik J, N\u00fa\u00f1ez Galindo A, Corth\u00e9sy J, Cominetti O, Oikonomidi A, Henry H, Migliavacca E, Bowman GL, Popp J (2017) Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer\u2019s Disease Pathology in Older Adults. J Alzheimers Dis 60:1641\u20131652","journal-title":"J Alzheimers Dis"},{"key":"1873_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT, Ernst J, McCabe C, Tang A, Raj T, Replogle J, Brodeur W, Gabriel S, Chai HS, Younkin C, Younkin SG, Zou F, Szyf M, Epstein CB, Schneider JA, Bernstein BE, Meissner A, Ertekin-Taner N, Chibnik LB, Kellis M, Mill J, Bennett DA (2014) Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17:1156\u20131163","journal-title":"Nat Neurosci"},{"key":"1873_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1515\/revneuro-2017-0042","volume":"29","author":"R Dehghani","year":"2018","unstructured":"Dehghani R, Rahmani F, Rezaei N (2018) MicroRNA in Alzheimer\u2019s disease revisited: implications for major neuropathological mechanisms. Rev Neurosci 29:161\u2013182","journal-title":"Rev Neurosci"},{"key":"1873_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","volume":"193","author":"S Dewanjee","year":"2022","unstructured":"Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A, Javvaji K, Pradhan SR, Vallamkondu J, Dey A, Kalra RS, Jha NK, Jha SK, Reddy PH, Kandimalla R (2022) Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med 193:134\u2013157","journal-title":"Free Radic Biol Med"},{"key":"1873_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.semcancer.2019.06.014","volume":"59","author":"D Donnelly","year":"2019","unstructured":"Donnelly D 3rd, Aung PP, Jour G (2019) The -OMICS facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers. Semin Cancer Biol 59:165\u2013174","journal-title":"Semin Cancer Biol"},{"key":"1873_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH (2021) Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol 20:484\u2013496","journal-title":"Lancet Neurol"},{"key":"1873_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.20517\/evcna.2023.13","volume":"4","author":"E Eitan","year":"2023","unstructured":"Eitan E, Thornton-Wells T, Elgart K, Erden E, Gershun E, Levine A, Volpert O, Azadeh M, Smith DG, Kapogiannis D (2023) Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer\u2019s disease: novel methodology and clinical proof of concept. Extracell vesicles circulating nucleic acids 4:133","journal-title":"Extracell vesicles circulating nucleic acids"},{"key":"1873_CR25","doi-asserted-by":"publisher","unstructured":"Feng JQ, Yang LL, Luo YX, Yao XQ (2026) Alzheimer\u2019s disease: from molecular pathways to therapies. Mol Biomed 7:43 https:\/\/doi.org\/10.1186\/s43556-026-00443-2","DOI":"10.1186\/s43556-026-00443-2"},{"key":"1873_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"101","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S (2021) The complexity of Alzheimer\u2019s disease: an evolving puzzle. Physiol Rev 101:1047\u20131081","journal-title":"Physiol Rev"},{"key":"1873_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fneur.2015.00237","volume":"6","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ (2015) Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer\u2019s Disease. Front Neurol 6:237","journal-title":"Front Neurol"},{"key":"1873_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.21038","volume":"61","author":"EJ Finehout","year":"2007","unstructured":"Finehout EJ, Franck Z, Choe LH, Relkin N, Lee KH (2007) Cerebrospinal fluid proteomic biomarkers for Alzheimer\u2019s disease. Ann Neurol 61:120\u2013129","journal-title":"Ann Neurol"},{"key":"1873_CR29","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.4161\/cc.10.19.17647","volume":"10","author":"A Formosa","year":"2011","unstructured":"Formosa A, Piro MC, Docimo R, Maturo P, Sollecito DR, Kalimutho M, Sancesario G, Barlattani A, Melino G, Candi E, Bernardini S (2011) Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages. Cell cycle (Georgetown Tex) 10:3359\u20133368","journal-title":"Cell cycle (Georgetown Tex)"},{"key":"1873_CR30","doi-asserted-by":"publisher","first-page":"103058","DOI":"10.1016\/j.arr.2026.103058","volume":"117","author":"W Fu","year":"2026","unstructured":"Fu W, Ho PC (2026) Blood-based biomarkers for Alzheimer\u2019s disease: Advances in early detection and monitoring of age-related neurodegeneration. Ageing Res Rev 117:103058","journal-title":"Ageing Res Rev"},{"key":"1873_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-022-02580-1","volume":"19","author":"C Gao","year":"2022","unstructured":"Gao C, Shen X, Tan Y, Chen S (2022) Pathogenesis, therapeutic strategies and biomarker development based on omics analysis related to microglia in Alzheimer\u2019s disease. J Neuroinflammation 19:215","journal-title":"J Neuroinflammation"},{"key":"1873_CR32","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1038\/s41598-019-44848-2","volume":"9","author":"VV Giau","year":"2019","unstructured":"Giau VV, Bagyinszky E, Yang YS, Youn YC, An SSA, Kim SY (2019) Genetic analyses of early-onset Alzheimer\u2019s disease using next generation sequencing. Sci Rep 9:8368","journal-title":"Sci Rep"},{"key":"1873_CR33","doi-asserted-by":"publisher","first-page":"e0119452","DOI":"10.1371\/journal.pone.0119452","volume":"10","author":"SF Graham","year":"2015","unstructured":"Graham SF, Chevallier OP, Elliott CT, H\u00f6lscher C, Johnston J, McGuinness B, Kehoe PG, Passmore AP, Green BD (2015) Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer\u2019s disease. PLoS ONE 10:e0119452","journal-title":"PLoS ONE"},{"key":"1873_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00216-016-0003-1","volume":"409","author":"SP Guiraud","year":"2017","unstructured":"Guiraud SP, Montoliu I, Da Silva L, Dayon L, Galindo AN, Corth\u00e9sy J, Kussmann M, Martin FP (2017) High-throughput and simultaneous quantitative analysis of homocysteine-methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC-MS\/MS. Anal Bioanal Chem 409:295\u2013305","journal-title":"Anal Bioanal Chem"},{"key":"1873_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1074\/mcp.M113.028639","volume":"13","author":"SH Han","year":"2014","unstructured":"Han SH, Kim JS, Lee Y, Choi H, Kim JW, Na DL, Yang EG, Yu MH, Hwang D, Lee C, Mook-Jung I (2014) Both targeted mass spectrometry and flow sorting analysis methods detected the decreased serum apolipoprotein E level in Alzheimer\u2019s disease patients. Mol Cell proteomics: MCP 13:407\u2013419","journal-title":"Mol Cell proteomics: MCP"},{"key":"1873_CR36","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CE (2022) The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 18:2669\u20132686","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1873_CR37","first-page":"14","volume":"1","author":"TM Harrison","year":"2016","unstructured":"Harrison TM, Bookheimer SY (2016) Neuroimaging genetic risk for Alzheimer\u2019s disease in preclinical individuals: From candidate genes to polygenic approaches. Biol psychiatry Cogn Neurosci neuroimaging 1:14\u201323","journal-title":"Biol psychiatry Cogn Neurosci neuroimaging"},{"key":"1873_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-023-01188-8","volume":"15","author":"C Hirtz","year":"2023","unstructured":"Hirtz C, Busto GU, Bennys K, Kindermans J, Navucet S, Tiers L, Lista S, Vialaret J, Gutierrez L-A, Dauvilliers Y (2023) Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer\u2019s disease diagnosis in a memory clinic cohort. Alzheimers Res Ther 15:34","journal-title":"Alzheimers Res Ther"},{"key":"1873_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neurobiolaging.2015.10.031","volume":"38","author":"TJ Hohman","year":"2016","unstructured":"Hohman TJ, Bush WS, Jiang L, Brown-Gentry KD, Torstenson ES, Dudek SM, Mukherjee S, Naj A, Kunkle BW, Ritchie MD, Martin ER, Schellenberg GD, Mayeux R, Farrer LA, Pericak-Vance MA, Haines JL, Thornton-Wells TA (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141\u2013150","journal-title":"Neurobiol Aging"},{"key":"1873_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5582\/ddt.2025.01055","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu S, Yu H, Gao J (2025) The pTau217\/A\u03b2(1\u201342) plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer\u2019s disease. Drug discoveries Ther 19:208\u2013209","journal-title":"Drug discoveries Ther"},{"key":"1873_CR41","doi-asserted-by":"publisher","unstructured":"Huang Y-A, Hu Y, Li Y-C, Cao X, Li X, Tan KC, You Z-H, Huang Z-A (2026) scBIT: Integrating Single-cell Transcriptomic Data into fMRI-based Prediction for Alzheimer\u2019s Disease Diagnosis. IEEE transactions on medical imaging. https:\/\/doi.org\/10.1109\/TMI.2026.3675606","DOI":"10.1109\/TMI.2026.3675606"},{"key":"1873_CR42","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1080\/10286020.2024.2371040","volume":"26","author":"Z Hui","year":"2024","unstructured":"Hui Z, Lai-Fa W, Xue-Qin W, Ling D, Bin-Sheng H, Li JM (2024) Mechanisms and therapeutic potential of chinonin in nervous system diseases. J Asian Nat Prod Res 26:1405\u20131420","journal-title":"J Asian Nat Prod Res"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"1614962","DOI":"10.3389\/fnagi.2025.1614962","volume":"17","author":"A Inamdar","year":"2025","unstructured":"Inamdar A, Bugadannavar P, Palled M, Umarani S, Salve P, Gurupadayya B, Patil P, Sharma H (2025) Biological determinants of blood-based biomarker levels in Alzheimer\u2019s disease: role of nutrition, inflammation, and metabolic factors. Front Aging Neurosci 17:1614962","journal-title":"Front Aging Neurosci"},{"key":"1873_CR44","doi-asserted-by":"publisher","first-page":"eabo6764","DOI":"10.1126\/sciadv.abo6764","volume":"8","author":"Y Iturria-Medina","year":"2022","unstructured":"Iturria-Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa-Neto P, O\u2019Donnell K, Petyuk VA, Gauthier S, De Jager PL, Breitner J, Bennett DA (2022a) Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer\u2019s disease progression and heterogeneity. Sci Adv 8:eabo6764","journal-title":"Sci Adv"},{"key":"1873_CR45","doi-asserted-by":"publisher","first-page":"eabo6764","DOI":"10.1126\/sciadv.abo6764","volume":"8","author":"Y Iturria-Medina","year":"2022","unstructured":"Iturria-Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa-Neto P, O\u2019Donnell K, Petyuk VA, Gauthier S, De Jager PL, Breitner J (2022b) Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer\u2019s disease progression and heterogeneity. Sci Adv 8:eabo6764","journal-title":"Sci Adv"},{"key":"1873_CR46","doi-asserted-by":"crossref","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, Molinuevo JL, Okonkwo OC, Pani L, Rafii MS, Scheltens P, Siemers E, Snyder HM, Sperling R, Teunissen CE, Carrillo MC (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association 20: 5143\u20135169","DOI":"10.1002\/alz.13859"},{"key":"1873_CR47","doi-asserted-by":"crossref","unstructured":"Jain AP, Sathe G (2021) Proteomics Landscape of Alzheimer\u2019s Disease. Proteomes 9","DOI":"10.3390\/proteomes9010013"},{"key":"1873_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, Liu J, Betarbet R, Ping L, Yin L, Serrano GE, Beach TG, Peng J, De Jager PL, Haroutunian V, Zhang B, Gaiteri C, Bennett DA, Gearing M, Wingo TS, Wingo AP, Lah JJ, Levey AI, Seyfried NT (2022) Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci 25:213\u2013225","journal-title":"Nat Neurosci"},{"key":"1873_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, J\u00f6nsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399","journal-title":"Nature"},{"key":"1873_CR50","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1038\/s41598-024-75636-2","volume":"14","author":"S Kang","year":"2024","unstructured":"Kang S, Wu Q, Shen J, Wu C (2024) CD27 is not an ideal marker for human memory B cells and can be modulated by IL-21 upon stimulated by Anti-CD40. Sci Rep 14:23742","journal-title":"Sci Rep"},{"key":"1873_CR51","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ajmg.b.31053","volume":"153b","author":"JS Kauwe","year":"2010","unstructured":"Kauwe JS, Bertelsen S, Mayo K, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM (2010) Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer\u2019s disease. Am J Med Genet Part B Neuropsychiatric genetics: official publication Int Soc Psychiatric Genet 153b:955\u2013959","journal-title":"Am J Med Genet Part B Neuropsychiatric genetics: official publication Int Soc Psychiatric Genet"},{"key":"1873_CR52","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","volume":"18","author":"M Kim","year":"2009","unstructured":"Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, Norton D, Tesco G, Elliott K, Wagner SL, Moir RD, Becker KD, Tanzi RE (2009) Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet 18:3987\u20133996","journal-title":"Hum Mol Genet"},{"key":"1873_CR53","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41598-022-05384-8","volume":"12","author":"Y Kim","year":"2022","unstructured":"Kim Y, Kim J, Son M, Lee J, Yeo I, Choi KY, Kim H, Kim BC, Lee KH, Kim Y (2022) Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry. Sci Rep 12:1282","journal-title":"Sci Rep"},{"key":"1873_CR54","doi-asserted-by":"publisher","unstructured":"Knapskog AB, Engedal K, Selb\u00e6k G, \u00d8kseng\u00e5rd AR (2021) [Alzheimer\u2019s disease \u2013 diagnosis and treatment]. Journal of the Norwegian Medical Association 141. https:\/\/doi.org\/10.4045\/tidsskr.20.0919","DOI":"10.4045\/tidsskr.20.0919"},{"key":"1873_CR55","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-142319","volume":"44","author":"T Koal","year":"2015","unstructured":"Koal T, Klavins K, Seppi D, Kemmler G, Humpel C (2015) Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-\u03b242, tau, and phospho-tau-181 levels. J Alzheimer\u2019s disease: JAD 44:1193\u20131201","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"1873_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1373\/clinchem.2006.078014","volume":"53","author":"MA Korolainen","year":"2007","unstructured":"Korolainen MA, Nyman TA, Nyyss\u00f6nen P, Hartikainen ES, Pirttil\u00e4 T (2007) Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem 53:657\u2013665","journal-title":"Clin Chem"},{"key":"1873_CR56","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1471-4159.2009.06558.x","volume":"112","author":"MA Korolainen","year":"2010","unstructured":"Korolainen MA, Nyman TA, Aittokallio T, Pirttil\u00e4 T (2010) An update on clinical proteomics in Alzheimer\u2019s research. J Neurochem 112:1386\u20131414","journal-title":"J Neurochem"},{"key":"1873_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/jne.12254","volume":"27","author":"S Kullmann","year":"2015","unstructured":"Kullmann S, Heni M, Fritsche A, Preissl H (2015) Insulin action in the human brain: evidence from neuroimaging studies. J Neuroendocrinol 27:419\u2013423","journal-title":"J Neuroendocrinol"},{"key":"1873_CR59","doi-asserted-by":"publisher","first-page":"e69807","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y (2013) Circulating miRNA biomarkers for Alzheimer\u2019s disease. PLoS ONE 8:e69807","journal-title":"PLoS ONE"},{"key":"1873_CR60","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Mor\u00f3n FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fi\u00e9vet N, Huentelman MW, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuiness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Boss\u00f9 P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Deniz Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F, Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannefelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O\u2019Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr., Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltuenen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, N\u00f6then MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458","journal-title":"Nat Genet"},{"key":"1873_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cmet.2020.02.004","volume":"31","author":"J Le Douce","year":"2020","unstructured":"Le Douce J, Maugard M, Veran J, Matos M, J\u00e9go P, Vigneron PA, Faivre E, Toussay X, Vandenberghe M, Balbastre Y, Piquet J, Guiot E, Tran NT, Taverna M, Marinesco S, Koyanagi A, Furuya S, Gaudin-Gu\u00e9rif M, Goutal S, Ghettas A, Pruvost A, Bemelmans AP, Gaillard MC, Cambon K, Stimmer L, Sazdovitch V, Duyckaerts C, Knott G, H\u00e9rard AS, Delzescaux T, Hantraye P, Brouillet E, Cauli B, Oliet SHR, Panatier A, Bonvento G (2020) Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer\u2019s Disease. Cell Metabol 31:503\u2013517e508","journal-title":"Cell Metabol"},{"key":"1873_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/17512433.2013.811237","volume":"6","author":"GC L\u00e9ger","year":"2013","unstructured":"L\u00e9ger GC, Massoud F (2013) Novel disease-modifying therapeutics for the treatment of Alzheimer\u2019s disease. Expert Rev Clin Pharmacol 6:423\u2013442","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1873_CR63","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, St\u00e4hler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14:R78","journal-title":"Genome Biol"},{"key":"1873_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-022-00323-z","volume":"11","author":"X Liang","year":"2022","unstructured":"Liang X, Fu Y, Cao WT, Wang Z, Zhang K, Jiang Z, Jia X, Liu CY, Lin HR, Zhong H, Miao Z, Gou W, Shuai M, Huang Y, Chen S, Zhang B, Chen YM, Zheng JS (2022) Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis. Translational neurodegeneration 11:49","journal-title":"Translational neurodegeneration"},{"key":"1873_CR65","doi-asserted-by":"publisher","first-page":"1418939","DOI":"10.3389\/fimmu.2024.1418939","volume":"15","author":"Z Liao","year":"2024","unstructured":"Liao Z, Zhang Q, Ren N, Zhao H, Zheng X (2024) Progress in mitochondrial and omics studies in Alzheimer\u2019s disease research: from molecular mechanisms to therapeutic interventions. Front Immunol 15:1418939","journal-title":"Front Immunol"},{"issue":"2","key":"1873_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/genes16020135","volume":"16","author":"SY LiuZ, Song","year":"2025","unstructured":"LiuZ,Song SY (2025) Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases. Genes 16(2):135. https:\/\/doi.org\/10.3390\/genes16020135","journal-title":"Genes"},{"key":"1873_CR67","doi-asserted-by":"publisher","first-page":"e103067","DOI":"10.1371\/journal.pone.0103067","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Deng Y, Yu D, Cao H, Wang L, Liu L, Yu C, Zhang Y, Guo X, Yu G (2014) Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer\u2019s disease. PLoS ONE 9:e103067","journal-title":"PLoS ONE"},{"key":"1873_CR68","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, Troakes C, Al-Sarraj S, Burrage J, Macdonald R, Condliffe D, Harries LW, Katsel P, Haroutunian V, Kaminsky Z, Joachim C, Powell J, Lovestone S, Bennett DA, Schalkwyk LC, Mill J (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci 17:1164\u20131170","journal-title":"Nat Neurosci"},{"key":"1873_CR69","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.arr.2021.101544","volume":"74","author":"YAR Mahaman","year":"2022","unstructured":"Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X (2022) Biomarkers used in Alzheimer\u2019s disease diagnosis, treatment, and prevention. Ageing Res Rev 74:101544","journal-title":"Ageing Res Rev"},{"key":"1873_CR70","doi-asserted-by":"crossref","unstructured":"Mansoori N, Tripathi M, Luthra K, Alam R, Lakshmy R, Sharma S, Arulselvi S, Parveen S, Mukhopadhyay AK (2012) MTHFR (677 and 1298) and IL-6-174 G\/C genes in pathogenesis of Alzheimer\u2019s and vascular dementia and their epistatic interaction. Neurobiology of aging 33: 1003.e1001-1008","DOI":"10.1016\/j.neurobiolaging.2011.09.018"},{"key":"1873_CR71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20:415\u2013418","journal-title":"Nat Med"},{"key":"1873_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","volume":"43","author":"JL Markley","year":"2017","unstructured":"Markley JL, Br\u00fcschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D, Wishart DS (2017) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34\u201340","journal-title":"Curr Opin Biotechnol"},{"key":"1873_CR73","doi-asserted-by":"publisher","first-page":"1150512","DOI":"10.3389\/fnagi.2023.1150512","volume":"15","author":"CR Marshall","year":"2023","unstructured":"Marshall CR, Farrow MA, Djambazova KV, Spraggins JM (2023) Untangling Alzheimer\u2019s disease with spatial multi-omics: a brief review. Front Aging Neurosci 15:1150512","journal-title":"Front Aging Neurosci"},{"key":"1873_CR74","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jnnp.2005.075358","volume":"77","author":"I Mateo","year":"2006","unstructured":"Mateo I, Infante J, Rodr\u00edguez E, Berciano J, Combarros O, Llorca J (2006) Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer\u2019s disease risk. J Neurol Neurosurg Psychiatry 77:278\u2013279","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1873_CR75","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, Martorell AJ, Ransohoff RM, Hafler BP, Bennett DA, Kellis M, Tsai LH (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570:332\u2013337","journal-title":"Nature"},{"key":"1873_CR76","doi-asserted-by":"crossref","unstructured":"Matthews H, Hanison J, Nirmalan N (2016) Omics-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives. Proteomes 4","DOI":"10.3390\/proteomes4030028"},{"key":"1873_CR77","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/jnr.25015","volume":"100","author":"G Mayorga-Weber","year":"2022","unstructured":"Mayorga-Weber G, Rivera FJ, Castro MA (2022) Neuron-glia (mis)interactions in brain energy metabolism during aging. J Neurosci Res 100:835\u2013854","journal-title":"J Neurosci Res"},{"key":"1873_CR78","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1002\/alz.14184","volume":"20","author":"MM Mielke","year":"2024","unstructured":"Mielke MM, Anderson M, Ashford JW, Jeromin A, Lin PJ, Rosen A, Tyrone J, Vandevrede L, Willis DR, Hansson O, Khachaturian AS, Schindler SE, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Braunstein JB, Burnham SC, de Oliveira FF, Hu YH, Mattke S, Merali Z, Monane M, Sabbagh MN, Shobin E, Weiner M, Udeh-Momoh CT (2024) Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 20:8216\u20138224","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1873_CR79","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F (2022) Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat reviews Neurol 18:643\u2013660","journal-title":"Nat reviews Neurol"},{"key":"1873_CR80","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486\u2013510","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1873_CR81","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD (2011) Nat Genet 43:436\u2013441 Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","journal-title":"Nat Genet"},{"key":"1873_CR82","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.nbd.2014.11.023","volume":"74","author":"PJ Narayan","year":"2015","unstructured":"Narayan PJ, Lill C, Faull R, Curtis MA, Dragunow M (2015) Increased acetyl and total histone levels in post-mortem Alzheimer\u2019s disease brain. Neurobiol Dis 74:281\u2013294","journal-title":"Neurobiol Dis"},{"key":"1873_CR83","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio R, Lan Y, Donahue G, Sidoli S, Berson A, Srinivasan AR, Shcherbakova O, Amlie-Wolf A, Nie J, Cui X, He C, Wang LS, Garcia BA, Trojanowski JQ, Bonini NM, Berger SL (2020) An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat Genet 52:1024\u20131035","journal-title":"Nat Genet"},{"key":"1873_CR84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10408363.2020.1833298","volume":"58","author":"D Navas-Carrillo","year":"2021","unstructured":"Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Pi\u00f1ero E (2021) Novel biomarkers in Alzheimer\u2019s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites. Crit Rev Clin Lab Sci 58:167\u2013179","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1873_CR85","doi-asserted-by":"publisher","first-page":"18717","DOI":"10.1038\/s41598-024-66693-8","volume":"14","author":"DPQ Nguyen","year":"2024","unstructured":"Nguyen DPQ, Pham S, Jallow AW, Ho N-T, Le B, Quang HT, Lin Y-F, Lin Y-F (2024) Multiple Transcriptomic Analyses Explore Potential Synaptic Biomarker Rabphilin-3A for Alzheimer\u2019s Disease. Sci Rep 14:18717","journal-title":"Sci Rep"},{"issue":"2","key":"1873_CR86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/biom11020195","volume":"11","author":"M NikolacPerkovic","year":"2021","unstructured":"NikolacPerkovic M, Videtic Paska A, Konjevod M, Kouter K, Svob Strac D, Nedic Erjavec G, Pivac N (2021) Epigenetics of Alzheimer\u2019s Disease. Biomolecules 11(2):195. https:\/\/doi.org\/10.3390\/biom11020195","journal-title":"Biomolecules"},{"key":"1873_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874609814666210302085232","volume":"15","author":"JO Ogbodo","year":"2022","unstructured":"Ogbodo JO, Agbo CP, Njoku UO, Ogugofor MO, Egba SI, Ihim SA, Echezona AC, Brendan KC, Upaganlawar AB, Upasani CD (2022) Alzheimer\u2019s Disease: Pathogenesis and Therapeutic Interventions. Curr Aging Sci 15:2\u201325","journal-title":"Curr Aging Sci"},{"key":"1873_CR88","doi-asserted-by":"crossref","unstructured":"Okhovat M, Layman C, Davis BA, Pederson A, O\u2019Niel A, Holden S, Kessler K, Acharya S, Wheeler KJ, Nevonen KA (2025) Epigenetic and Transcriptomic Alterations Precede Amyloidosis in the Hippocampus of the Alzheimer\u2019s Disease AppNL-GF Knock in Mouse Model. bioRxiv: 2025.2002. 2020.639336","DOI":"10.1038\/s41598-025-28244-7"},{"issue":"19","key":"1873_CR89","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3390\/ijms20194781","volume":"20","author":"R OlivierM, Asmis","year":"2019","unstructured":"OlivierM, Asmis R, Hawkins GA, Howard TD, Cox LA (2019) The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Int J Mol Sci 20(19):4781. https:\/\/doi.org\/10.3390\/ijms20194781","journal-title":"Int J Mol Sci"},{"key":"1873_CR90","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Dage JL, Reiman EM, Hansson O (2020) Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA 324:772\u2013781","journal-title":"JAMA"},{"key":"1873_CR91","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, Okrahvi HR, Paczynski M, Schindler SE, Teunissen CE, Zetterberg H, Carrillo MC, Edelmayer RM, Mahinrad S, McAteer MB, Kahale LA, Pahlke S, Tampi MP (2025) Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association 21: e70535","DOI":"10.1002\/alz.70535"},{"issue":"12","key":"1873_CR92","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.3390\/ijms25126295","volume":"25","author":"N ParkY, Kc","year":"2024","unstructured":"ParkY,Kc N, Paneque A, Cole PD (2024) Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases. Int J Mol Sci 25(12):6295. https:\/\/doi.org\/10.3390\/ijms25126295","journal-title":"Int J Mol Sci"},{"key":"1873_CR93","doi-asserted-by":"publisher","first-page":"106192","DOI":"10.1016\/j.nbd.2023.106192","volume":"184","author":"PJ Patel","year":"2023","unstructured":"Patel PJ, Ren Y, Yan Z (2023) Epigenomic analysis of Alzheimer\u2019s disease brains reveals diminished CTCF binding on genes involved in synaptic organization. Neurobiol Dis 184:106192","journal-title":"Neurobiol Dis"},{"key":"1873_CR94","doi-asserted-by":"publisher","first-page":"1443865","DOI":"10.3389\/fninf.2024.1443865","volume":"18","author":"AP P\u00e9rez-Gonz\u00e1lez","year":"2024","unstructured":"P\u00e9rez-Gonz\u00e1lez AP, Garc\u00eda-Kroepfly AL, P\u00e9rez-Fuentes KA, Garc\u00eda-Reyes RI, Solis-Roldan FF, Alba-Gonz\u00e1lez JA, Hern\u00e1ndez-Lemus E, de Anda-J\u00e1uregui G (2024) The ROSMAP project: aging and neurodegenerative diseases through omic sciences. Front neuroinformatics 18:1443865","journal-title":"Front neuroinformatics"},{"key":"1873_CR95","first-page":"3","volume":"2785","author":"R Perneczky","year":"2024","unstructured":"Perneczky R, Hansen N, Hofmann A, Laske C, Priller J, Grimmer T, Fr\u00f6lich L, D\u00fczel E, Jessen F, Wiltfang J (2024) Blood-Based Biomarkers for Early Alzheimer\u2019s Disease Diagnosis in Real-World Settings. Methods in molecular biology. (Clifton NJ) 2785:3\u201314","journal-title":"(Clifton NJ)"},{"key":"1873_CR96","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette A, Gaiteri C, Wennstr\u00f6m M, Kumar A, Hristovska I, Spotorno N, Salvad\u00f3 G, Strandberg O, Mathys H, Tsai LH, Palmqvist S, Mattsson-Carlgren N, Janelidze S, Stomrud E, Vogel JW, Hansson O (2024) Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and tau tangle pathologies. Nat Neurosci 27:1880\u20131891","journal-title":"Nat Neurosci"},{"key":"1873_CR97","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.2174\/138161211797416039","volume":"17","author":"E Portelius","year":"2011","unstructured":"Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H (2011) Novel a\u03b2 isoforms in Alzheimer\u2019s disease - their role in diagnosis and treatment. Curr Pharm Design 17:2594\u20132602","journal-title":"Curr Pharm Design"},{"key":"1873_CR98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","volume":"118","author":"M Puchades","year":"2003","unstructured":"Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer\u2019s disease. Brain Res Mol brain Res 118:140\u2013146","journal-title":"Brain Res Mol brain Res"},{"key":"1873_CR99","doi-asserted-by":"publisher","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG, Mukherjee S, Crane PK, Kauwe JS (2013) Alzheimer\u2019s disease: analyzing the missing heritability. PLoS ONE 8:e79771","journal-title":"PLoS ONE"},{"key":"1873_CR100","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3233\/JAD-230359","volume":"97","author":"JM Robillard","year":"2024","unstructured":"Robillard JM, Masellis M, Martin SE, Khachaturian AS, Dixon RA (2024) The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility. J Alzheimers Dis 97:1083\u20131090","journal-title":"J Alzheimers Dis"},{"key":"1873_CR101","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee W, Wang D, Hartmann K, Toland AE (2023) Pharmacogenomics: Driving Personalized Medicine. Pharmacol Rev 75:789\u2013814","journal-title":"Pharmacol Rev"},{"key":"1873_CR102","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1212\/01.wnl.0000437306.37850.22","volume":"81","author":"C Sala Frigerio","year":"2013","unstructured":"Sala Frigerio C, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R, Wallin A, Bjerke M, Zetterberg H, Blennow K, De Strooper B (2013) Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology 81:2103\u20132106","journal-title":"Neurology"},{"key":"1873_CR103","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","volume":"179","author":"E Salmon","year":"2024","unstructured":"Salmon E, Collette F, Bastin C (2024) Cerebral glucose metabolism in Alzheimer\u2019s disease. Cortex 179:50\u201361","journal-title":"Cortex"},{"key":"1873_CR104","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","volume":"9","author":"JV Sanchez-Mut","year":"2015","unstructured":"Sanchez-Mut JV, Gr\u00e4ff J (2015) Epigenetic Alterations in Alzheimer\u2019s Disease. Front Behav Neurosci 9:347","journal-title":"Front Behav Neurosci"},{"key":"1873_CR105","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet (London England) 397:1577\u20131590","journal-title":"Lancet (London England)"},{"key":"1873_CR106","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","volume":"20","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Su\u00e1rez-Calvet M, Khachaturian AS, Mielke MM, Udeh-Momoh C, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Algeciras-Schimnich A, Aubrecht J, Braunstein JB, Hendrix J, Hu YH, Mattke S, Monane M, Reilly D, Somers E, Teunissen CE, Shobin E, Vanderstichele H, Weiner MW, Wilson D, Hansson O (2024) Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease. Nat reviews Neurol 20:426\u2013439","journal-title":"Nat reviews Neurol"},{"key":"1873_CR107","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"1873_CR108","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bbapap.2015.01.016","volume":"1854","author":"G Shevchenko","year":"2015","unstructured":"Shevchenko G, Konzer A, Musunuri S, Bergquist J (2015) Neuroproteomics tools in clinical practice. Biochim Biophys Acta 1854:705\u2013717","journal-title":"Biochim Biophys Acta"},{"key":"1873_CR109","first-page":"253","volume":"43","author":"DH Silverman","year":"2002","unstructured":"Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME (2002) Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J nuclear medicine: official publication Soc Nuclear Med 43:253\u2013266","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"key":"1873_CR110","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM (2023) Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA 330:512\u2013527","journal-title":"JAMA"},{"key":"1873_CR111","doi-asserted-by":"publisher","first-page":"825729","DOI":"10.3389\/fcell.2021.825729","volume":"9","author":"H Song","year":"2022","unstructured":"Song H, Yang J, Yu W (2022) Promoter hypomethylation of TGFBR3 as a risk factor of Alzheimer\u2019s disease: An integrated epigenomic-transcriptomic analysis. Front Cell Dev Biology 9:825729","journal-title":"Front Cell Dev Biology"},{"key":"1873_CR112","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"R Sultana","year":"2013","unstructured":"Sultana R, Perluigi M, Butterfield DA (2013) Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 62:157\u2013169","journal-title":"Free Radic Biol Med"},{"key":"1873_CR113","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1177\/13872877251408510","volume":"109","author":"S Suresh","year":"2026","unstructured":"Suresh S, Maffei L, Bauermeister S, Raymont V (2026) Blood biomarkers for diagnosis and differential diagnosis of Alzheimer\u2019s disease in real-world clinical populations: A systematic review. J Alzheimer\u2019s disease: JAD 109:1574\u20131589","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"1873_CR114","doi-asserted-by":"crossref","unstructured":"Tao L, Xie Y, Deng JD, Shen H, Deng HW, Zhou W, Zhao C (2024) SGUQ: Staged Graph Convolution Neural Network for Alzheimer\u2019s Disease Diagnosis using Multi-Omics Data. ArXiv","DOI":"10.2139\/ssrn.5007474"},{"issue":"9","key":"1873_CR115","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/ijms17091555","volume":"17","author":"C TebaniA, Afonso","year":"2016","unstructured":"TebaniA,Afonso C, Marret S, Bekri S (2016) Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations. Int J Mol Sci 17(9):1555. https:\/\/doi.org\/10.3390\/ijms17091555","journal-title":"Int J Mol Sci"},{"key":"1873_CR116","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377","journal-title":"Lancet Neurol"},{"key":"1873_CR117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","volume":"1362","author":"A Thorsell","year":"2010","unstructured":"Thorsell A, Bjerke M, Gobom J, Brunhage E, Vanmechelen E, Andreasen N, Hansson O, Minthon L, Zetterberg H, Blennow K (2010) Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer\u2019s disease. Brain Res 1362:13\u201322","journal-title":"Brain Res"},{"key":"1873_CR118","doi-asserted-by":"publisher","first-page":"fcaf410","DOI":"10.1093\/braincomms\/fcaf410","volume":"7","author":"P Tiwari","year":"2025","unstructured":"Tiwari P, Gupta A, Kaushik M, Yadav A, Anjali A, Dwivedi R, Mudgal P, Kumar Y, Tripathi M, Dada R (2025) Comprehensive metabolomics profiling reveals novel biomarkers and pathways for early detection of Alzheimer\u2019s disease. Brain Commun 7:fcaf410","journal-title":"Brain Commun"},{"key":"1873_CR119","doi-asserted-by":"crossref","unstructured":"Toledo JB, Arnold M, Kastenm\u00fcller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, Risacher SL, Blach C, Lucas JE, Massaro T, Louie G, Zhu H, Dallmann G, Klavins K, Koal T, Kim S, Nho K, Shen L, Casanova R, Varma S, Legido-Quigley C, Moseley MA, Zhu K, Henrion MYR, van der Lee SJ, Harms AC, Demirkan A, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Saykin AJ, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R (2017) Metabolic network failures in Alzheimer\u2019s disease: A biochemical road map. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association 13: 965\u2013984","DOI":"10.1016\/j.jalz.2017.01.020"},{"key":"1873_CR120","doi-asserted-by":"publisher","first-page":"107772","DOI":"10.1016\/j.parkreldis.2025.107772","volume":"134","author":"E Vacchi","year":"2025","unstructured":"Vacchi E, Ruiz-Barrio I, Melli G (2025) Tau biomarkers for neurodegenerative diseases: Current state and perspectives. Parkinsonism Relat Disord 134:107772","journal-title":"Parkinsonism Relat Disord"},{"key":"1873_CR121","doi-asserted-by":"publisher","first-page":"1390607","DOI":"10.3389\/fbinf.2024.1390607","volume":"4","author":"M Vacher","year":"2024","unstructured":"Vacher M, Canovas R, Laws SM, Doecke JD (2024) A comprehensive multi-omics analysis reveals unique signatures to predict Alzheimer\u2019s disease. Front Bioinf 4:1390607","journal-title":"Front Bioinf"},{"key":"1873_CR122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"1873_CR124","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jns.2017.07.044","volume":"380","author":"XF Wang","year":"2017","unstructured":"Wang XF, Lin X, Li DY, Zhou R, Greenbaum J, Chen YC, Zeng CP, Peng LP, Wu KH, Ao ZX, Lu JM, Guo YF, Shen J, Deng HW (2017) Linking Alzheimer\u2019s disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach. J Neurol Sci 380:262\u2013272","journal-title":"J Neurol Sci"},{"key":"1873_CR123","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H, Dey KK, Chen PC, Li Y, Niu M, Cho JH, Wang X, Bai B, Jiao Y, Chepyala SR, Haroutunian V, Zhang B, Beach TG, Peng J (2020) Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener 15:43","journal-title":"Mol Neurodegener"},{"key":"1873_CR125","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fneur.2019.01223","volume":"10","author":"WC Weng","year":"2019","unstructured":"Weng WC, Huang WY, Tang HY, Cheng ML, Chen KH (2019) The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer\u2019s Disease and Mild Cognitive Impairment. Front Neurol 10:1223","journal-title":"Front Neurol"},{"key":"1873_CR126","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1016\/j.cell.2023.08.040","volume":"186","author":"X Xiong","year":"2023","unstructured":"Xiong X, James BT, Boix CA, Park YP, Galani K, Victor MB, Sun N, Hou L, Ho L-L, Mantero J (2023) Epigenomic dissection of Alzheimer\u2019s disease pinpoints causal variants and reveals epigenome erosion. Cell 186:4422\u20134437 e4421","journal-title":"Cell"},{"key":"1873_CR127","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1016\/j.apsb.2025.07.018","volume":"15","author":"Y Yang","year":"2025","unstructured":"Yang Y, Diao Y, Jiang L, Li F, Chen L, Ni M, Wang Z, Fang H (2025) A computational medicine framework integrating multi-omics, systems biology, and artificial neural networks for Alzheimer\u2019s disease therapeutic discovery. Acta Pharm Sinica B 15:4411\u20134426","journal-title":"Acta Pharm Sinica B"},{"key":"1873_CR128","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F (2023) Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J 290:1420\u20131453","journal-title":"FEBS J"},{"key":"1873_CR129","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/brainsci12081022","volume":"12","author":"Q-S Yu","year":"2022","unstructured":"Yu Q-S, Feng W-Q, Shi L-L, Niu R-Z, Liu J (2022) Integrated analysis of cortex single-cell transcriptome and serum proteome reveals the novel biomarkers in Alzheimer\u2019s disease. Brain Sci 12:1022","journal-title":"Brain Sci"},{"key":"1873_CR130","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1007\/s12598-024-03205-7","volume":"44","author":"K-S Yuan","year":"2025","unstructured":"Yuan K-S, Deng C-C, Wang X-X, Li Y-C, Zhou C, Zhao C-R, Dai X-Z, Khan A-R, Zhang Z, Guidoin R (2025) Research advances and future perspectives of zinc-based biomaterials for additive manufacturing. Rare Met 44:4376\u20134410","journal-title":"Rare Met"},{"key":"1873_CR131","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","volume":"19","author":"X Zeng","year":"2024","unstructured":"Zeng X, Lafferty TK, Sehrawat A, Chen Y, Ferreira PC, Bellaver B, Povala G, Kamboh MI, Klunk WE, Cohen AD (2024) Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease. Mol Neurodegeneration 19:68","journal-title":"Mol Neurodegeneration"},{"key":"1873_CR132","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/pmic.201200010","volume":"12","author":"K Zhang","year":"2012","unstructured":"Zhang K, Schrag M, Crofton A, Trivedi R, Vinters H, Kirsch W (2012) Targeted proteomics for quantification of histone acetylation in Alzheimer\u2019s disease. Proteomics 12:1261\u20131268","journal-title":"Proteomics"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01873-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:02:44Z","timestamp":1780729364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01873-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01873-1","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"During the preparation of this work, the author(s) used ChatGPT to correct the grammatical and typographical errors in the manuscript. All authors have approved the final version of the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"128"}}